The added value of a new high-performance ring-gantry CBCT imaging system for prostate cancer patients

Authors: Kunnen, Britt, J.A.J. van de Schoot, Agustinus, Fremeijer, Kimm P., Nicolai-Koornneef, Elise M., Offereins-van Harten, Kirsten, Sluijter, Judith H., Sijtsema, Nienke D., Oomen-de Hoop, Esther, el Yaakoubi, Abdelmounaim, Froklage, Femke E., de Vries, Kim C., Dirkx, Maarten L.P., Penninkhof, Joan J., Petit, Steven F.

Source: In Radiotherapy and Oncology November 2024 200

A review of trials investigating ctDNA-guided adjuvant treatment of solid tumors: The importance of trial design

Authors: Verschoor, Noortje, Bos, Manouk K., Oomen-de Hoop, Esther, Martens, John W.M., Sleijfer, Stefan, Jager, Agnes, Beije, Nick

Source: In European Journal of Cancer August 2024 207

Sex and Common Germline Variants Affect the Toxicity Profile and Pharmacokinetics of Alectinib: A Nationwide Cohort Study in Patients With ALK-Positive NSCLC

Authors: Heersche, Niels ^{a, b}, Lanser, Daan A.C. ^{a, b, c}, Muntinghe-Wagenaar, M. Benthe ^d, Mohmaed Ali, Ma Ida ^e, Ulas, Ezgi B. ^f, Trooster, Tessa M.A. ^b, de Jonge, Evert ^b, Oomen-de Hoop, Esther ^a, Paats, Marthe S. ^c, Bahce, Idris ^f, Croes, Sander ^g, Hendriks, Lizza E.L. ^h, van der Wekken, Anthonie J. ^d, Dingemans, Anne-Marie C. ^c, Huitema, Alwin D.R. ^{e, i, j}, van Schaik, Ron H.N. ^b, Mathijssen, Ron H.J. ^{a, ∗}, Veerman, G.D. Marijn ^{a, c}

Source: In Journal of Thoracic Oncology November 2024

The interplay between tamoxifen and endoxifen plasma concentrations and coagulation parameters in patients with primary breast cancer

Authors: Buijs, Sanne M., van Dorst, Daan C.H., Kruip, Marieke J.H.A., van den Akker, Rob F.P., Cheung, Ka L., Porrazzo, Robert, Oomen-de Hoop, Esther, Jager, Agnes, Koolen, Stijn L.W., Versmissen, Jorie, Jan Danser, A.H., Versteeg, Henri H., Bos, Mettine H.A., Mathijssen, Ron H.J.

Source: In Biomedicine & Pharmacotherapy January 2024 170

MFast‐SeqS‐based aneuploidy score in circulating cell‐free DNA is a prognostic biomarker in prostate cancer

Authors: Isebia, Khrystany T., Mostert, Bianca, Deger, Teoman, Kraan, Jaco, Weerd, Vanja, Oomen‐de Hoop, Esther, Hamberg, Paul, Haberkorn, Brigitte C. M., Helgason, Helgi H., Wit, Ronald, Mathijssen, Ron H. J., Lolkema, Martijn P., Wilting, Saskia M., Riet, Job, Martens, John W. M.

Source: Molecular oncology. 17(9):1898-1907

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100192051446.0x000001&indx=1&recIds=ETOCvdc_100192051446.0x000001

A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide

Authors: Buck, Stefan A.J., Meertens, Marinda, van Ooijen, Frederiek M.F., Oomen-de Hoop, Esther, de Jonge, Evert, Coenen, Marieke J.H., Bergman, Andries M., Koolen, Stijn L.W., de Wit, Ronald, Huitema, Alwin D.R., van Schaik, Ron H.N., Mathijssen, Ron H.J.

Source: In Biomedicine & Pharmacotherapy 31 December 2023 169

Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer

Authors: Veerman, G.D. Marijn, Boosman, Rene J., Jebbink, Merel, Oomen-de Hoop, Esther, van der Wekken, Anthonie J., Bahce, Idris, Hendriks, Lizza E.L., Croes, Sander, Steendam, Christi M.J., de Jonge, Evert, Koolen, Stijn L.W., Steeghs, Neeltje, van Schaik, Ron H.N., Smit, Egbert F., Dingemans, Anne-Marie C., Huitema, Alwin D.R., Mathijssen, Ron H.J.

Source: In eClinicalMedicine May 2023 59

Capecitabine-induced hand-foot syndrome: A pharmacogenetic study beyond DPYD

Authors: de With, Mirjam, van Doorn, Leni, Maasland, Demi C., Mulder, Tessa A.M., Oomen-de Hoop, Esther, Mostert, Bianca, Homs, Marjolein Y.V., El Bouazzaoui, Samira, Mathijssen, Ron H.J., van Schaik, Ron H.N., Bins, Sander

Source: In Biomedicine & Pharmacotherapy March 2023 159

CABA-V7: a prospective biomarker selected trial of cabazitaxel treatment in AR-V7 positive prostate cancer patients

Authors: Isebia, Khrystany T., Mostert, Bianca, Belderbos, Bodine P.S., Buck, Stefan A.J., Helmijr, Jean C.A., Kraan, Jaco, Beaufort, Corine M., Van, Mai N., Oomen - de Hoop, Esther, Sieuwerts, Anieta M., van IJcken, Wilfred F.J., van den Hout - van Vroonhoven, Mirjam C.G.N., Brouwer, Rutger W.W., Oole, Edwin, Hamberg, Paul, Haberkorn, Brigitte C.M., Helgason, Helgi H., de Wit, Ronald, Sleijfer, Stefan, Mathijssen, Ron H.J., Martens, John W.M., Jansen, Maurice P.H.M., van Riet, Job, Lolkema, Martijn P.

Source: In European Journal of Cancer December 2022 177:33-44

The course of C-peptide levels in patients developing diabetes during anti-PD-1 therapy

Authors: Basak, Edwin A., de Joode, Karlijn, Uyl, Tom J.J., van der Wal, Ronald, Schreurs, Marco W.J., van den Berg, Sjoerd A.A., Oomen-de Hoop, Esther, van der Leest, Cor H., Chaker, Layal, Feelders, Richard A., van der Veldt, Astrid A.M., Joosse, Arjen, Koolen, Stijn L.W., Aerts, Joachim G.J.V., Mathijssen, Ron H.J., Bins, Sander

Source: In Biomedicine & Pharmacotherapy December 2022 156

Influence of esomeprazole on the bioavailability of afatinib: A pharmacokinetic cross-over study in patients with non-small cell lung cancer

Authors: Veerman, G.D. Marijn, Hurkmans, Daan P., Paats, Marthe S., Oomen-de Hoop, Esther, van der Leest, Cor H., van Thiel, Eric R.E., Aerts, Joachim G.J.V., van Leeuwen, Roelof W., Dingemans, Anne-Marie C., Mathijssen, Ron H.J.

Source: In Biomedicine & Pharmacotherapy November 2022 155

Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study

Authors: Basak, Edwin A., Vermeer, Niels S., de Joode, Karlijn, Hurkmans, Daan P., Velthuis, Dorian E.M., Oomen-de Hoop, Esther, Schreurs, Marco W.J., Bins, Sander, Koolen, Stijn L.W., Debets, Reno, van der Veldt, Astrid A.M., Aerts, Joachim G.J.V., Joosse, Arjen, Mathijssen, Ron H.J.

Source: In European Journal of Cancer October 2022 174:113-120

Effect of the Proton Pump Inhibitor Esomeprazole on the Systemic Exposure of Capecitabine: Results of A Randomized Crossover Trial

Authors: Doorn, Leni, Heersche, Niels, Man, Femke M., Bruijn, Peter, Bijl, Ivo, Oomen‐de Hoop, Esther, Eskens, Ferry A. L. M., Gaast, Ate, Mathijssen, Ron H. J., Bins, Sander

Source: Clinical pharmacology & therapeutics. 111(2):455-460

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100138901378.0x000001&indx=1&recIds=ETOCvdc_100138901378.0x000001

Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium

Authors: de Joode, Karlijn, Tol, Jolien, Hamberg, Paul, Cloos, Marissa, Kastelijn, Elisabeth A., Borgers, Jessica S.W., Nuij, Veerle J.A.A., Klaver, Yarne, Herder, Gerarda J.M., Mutsaers, Pim G.N.J., Dumoulin, Daphne W., Oomen-de Hoop, Esther, van Diemen, Nico G.J., Libourel, Eduard J., Geraedts, Erica J., Bootsma, Gerben P., van der Leest, Cor H., Peerdeman, Anne L., Herbschleb, Karin H., Visser, Otto J., Bloemendal, Haiko J., van Laarhoven, Hanneke W.M., de Vries, Elisabeth G.E., Hendriks, Lizza E.L., Beerepoot, Laurens V., Westgeest, Hans M., van den Berkmortel, Franchette W.P.J., Haanen, John B.A.G., Dingemans, Anne-Marie C., van der Veldt, Astrid A.M.

Source: European journal of cancer. 160:261-272

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100151123983.0x000001&indx=1&recIds=ETOCvdc_100151123983.0x000001

The influence of green tea extract on nintedanib’s bioavailability in patients with pulmonary fibrosis

Authors: Veerman, G.D.Marijn, van der Werff, Sanne C., Koolen, Stijn L.W., Miedema, Jelle R., Oomen-de Hoop, Esther, van der Mark, Sophie C., Chandoesing, Prewesh P., de Bruijn, Peter, Wijsenbeek, Marlies S., Mathijssen, Ron H.J.

Source: In Biomedicine & Pharmacotherapy July 2022 151

Effects of Implementation of a Standardized Palliative Care Pathway for Patients with Advanced Cancer in a Hospital: A Prospective Pre- and Postintervention Study

Authors: van der Padt-Pruijsten, Annemieke, Leys, Maria B.L., Oomen-de Hoop, Esther, van der Heide, Agnes, van der Rijt, Carin C.D.

Source: In Journal of Pain and Symptom Management September 2021 62(3):451-459

Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients

Authors: Mendelaar, Pauline A. J., Kraan, Jaco, Van, Mai, Zeune, Leonie L., Terstappen, Leon W. M. M., Oomen‐de Hoop, Esther, Martens, John W. M., Sleijfer, Stefan

Source: Molecular oncology. 15(1):116-125

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100122950210.0x000001&indx=1&recIds=ETOCvdc_100122950210.0x000001

Effects of Protein and Calorie Restriction on the Metabolism and Toxicity Profile of Irinotecan in Cancer Patients

Authors: Man, Femke M., Eerden, Ruben A.G., Doorn, Gerdien M., Oomen‐de Hoop, Esther, Koolen, Stijn L.W., Olieman, Joanne F., Bruijn, Peter, Veraart, Joris N., Halteren, Henk K., Sandberg, Yorick, Moelker, Adriaan, IJzermans, Jan N.M., Lolkema, Martijn P., Gelder, Teun, Dollé, Martijn E.T., Bruin, Ron W.F., Mathijssen, Ron H.J.

Source: Clinical pharmacology & therapeutics. 109(5):1304-1313

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100120013154.0x000001&indx=1&recIds=ETOCvdc_100120013154.0x000001

Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study

Authors: van Loenhout, C.J., van der Leest, C.H., Becker-Commissaris, A., Borgers, J.S.W., Terhegggen, F., van den Borne, B.E.E.M., van Warmerdam, L.J.C., van Leeuwen, L., van der Meer, F.S., Tiemessen, M.A., van Diepen, D.M., Klaver, Y., Hamberg, A.P., Libourel, E.J., Strobbe, L., Cloos, M., Geraedts, E.J., Drooger, J.C., Heller, R., de Groot, J.W.B., Stigt, J.A., Nuij, V.J.A.A., Pitz, C.C.M., Slingerland, M., Borm, F.J., Haberkorn, B.C.M., Westeinde, S.C. van 't, Aarts, M.J.B., van Putten, J.W.G., Youssef, M., Cirkel, G.A., Herder, G.J.M., van Rooijen, C.R., Citgez, E., Barlo, N.P., Scholtes, B.M.J., Koornstra, R.H.T., Claessens, N.J.M., Faber, L.M., Rikers, C.H., van de Wetering, R.A.W., Veurink, G.L., Bouter, B.W., Houtenbos, I., Bard, M.P.L., Herbschleb, K.H., Kastelijn, E.A., Brocken, P., Douma, G., Jalving, M., Hiltermann, T.J.N., Schuurbiers-Siebers, O.C.J., Suijkerbuijk, K.P.M., van Lindert, A.S.R., van de Wouw, A.J., van den Boogaart, V.E.M., Bakker, S.D., Looysen, E., Peerdeman, A.L., de Jong, W.K., Siemerink, E.J.M., Staal, A.J., Franken, B., van Geffen, W.H., Bootsma, G.P., de Joode, Karlijn, Dumoulin, Daphne W., Tol, Jolien, Westgeest, Hans M., Beerepoot, Laurens V., van den Berkmortel, Franchette W.P.J., Mutsaers, Pim G.N.J., van Diemen, Nico G.J., Visser, Otto J., Oomen-de Hoop, Esther, Bloemendal, Haiko J., van Laarhoven, Hanneke W.M., Hendriks, Lizza E.L., Haanen, John B.A.G., de Vries, Elisabeth G.E., Dingemans, Anne-Marie C., van der Veldt, Astrid A.M.

Source: In European Journal of Cancer December 2020 141:171-184

This result is not displayed to guests.
Login for full access.